Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung

(2010) Sonam A. Shah et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk

(2009) Patricia González-Arriaga et al.   BMC CANCER

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis

(2009) D. B. Scherf et al.   EUROPEAN RESPIRATORY JOURNAL

Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects

(2009) Peter McColgan et al.   INTERNATIONAL JOURNAL OF CANCER

Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer

(2008) W. Sauter et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Putative functional polymorphisms ofMMP9predict survival of NSCLC in a Chinese population

(2008) Guangfu Jin et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor Response to Combination Celecoxib and Erlotinib Therapy in Non-small Cell Lung Cancer Is Associated with a Low Baseline Matrix Metalloproteinase-9 and a Decline in Serum-Soluble E-Cadherin

(2008) Karen L. Reckamp et al.   Journal of Thoracic Oncology